What is BrainCheck?
BrainCheck operates at the intersection of neurology and digital health, providing a sophisticated platform for cognitive assessment and care planning. Its flagship product, BrainCheck Assess, is an FDA Class II medical device designed to deliver standardized, repeatable cognitive metrics. By offering a technology-driven complement to traditional professional evaluations, the platform empowers clinicians to create personalized care protocols and monitor cognitive health trajectories with unprecedented precision.
The company's market position is defined by its commitment to evidence-based medicine. Unlike diagnostic tools that operate in isolation, BrainCheck integrates seamlessly into existing clinical and research environments, facilitating structured decision-making. This focus on clinical utility has made it a preferred partner for healthcare providers seeking to modernize their approach to cognitive health management.
How much funding has BrainCheck raised?
BrainCheck has raised a total of $39.2M across 9 funding rounds:
Private Equity
$2.2M
Angel/Seed
$1.2M
Unspecified
$1.5M
Series A
$8M
Debt
$150K
Debt
$338K
Series B
$10M
Other Financing Round
$15M
Private Equity (2016): $2.2M, investors not publicly disclosed
Angel/Seed (2017): $1.2M supported by True Wealth Ventures
Unspecified (2018): $1.5M featuring Tensility Venture Partners, S3 Ventures, True Wealth Ventures, and XFactor Ventures
Series A (2019): $8M backed by S3 Ventures, True Wealth Ventures, Nueterra Capital, and Tensility Venture Partners
Debt (2020): $150K with participation from PPP
Debt (2021): $338K led by PPP
Series B (2021): $10M supported by Next Coast Ventures, S3 Ventures, Nueterra Capital, and Tensility Venture Partners
Other Financing Round (2024): $15M featuring Next Coast Ventures and S3 Ventures
Key Investors in BrainCheck
S3 Ventures
S3 Ventures is the largest venture capital firm focused on Texas, partnering with startups across major cities to drive innovation in healthcare technology and business software.
True Wealth Ventures
True Wealth Ventures is a gender-lens venture capital fund that invests in women-led companies developing consumer health and sustainable technologies.
Nueterra Capital
Nueterra Capital specializes in the integration of healthcare and technology, providing strategic support to emerging startups that enhance healthcare delivery.
What's next for BrainCheck?
With the successful closure of this major strategic investment, BrainCheck is well-positioned to accelerate its product roadmap and expand its footprint in the digital health ecosystem. The company is expected to prioritize the enhancement of its data analytics capabilities and the broader adoption of its care planning tools across diverse clinical settings.
Strategic focus will likely remain on deepening partnerships with healthcare systems to drive the integration of cognitive health into routine patient care. As the demand for objective, longitudinal cognitive data grows, BrainCheck's ability to provide actionable insights will be central to its long-term value proposition. The firm remains focused on scaling its impact, ensuring that its technology continues to serve as a cornerstone for cognitive health innovation.
